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Abstract 
The transcriptional regulatory network that controls the determination and 
differentiation of skeletal muscle cells in the embryo has at its core the four Myogenic 
Regulatory Factors (MRFs), Myf5, MyoD, Mrf4 and Myogenin. These bHLH 
transcription factors act by binding, as obligate heterodimers with the ubiquitously 
expressed E proteins, to the E-box sequence CANNTG. While all skeletal muscle 
cells have the same underlying function their progenitors arise at many sites in the 
embryo and it has become apparent that the upstream activators of the cascade 
differ in these various populations so that it can be switched on by a variety of 
inductive signals, some of which act by initiating transcription, some by maintaining it. 
The application of genome wide approaches has provided important new information 
as to how the MRFs function to activate the terminal differentiation programme and 
some of these data provide significant mechanistic insights into questions which 
have exercised the field for many years. We also consider the emerging roles played 
by miRNAs in the regulation of both upstream activators and terminal differentiation 
genes. 
Introduction 
The formation of skeletal muscle provides one of the best models for studying 
the processes of cellular specification and differentiation and of organogenesis. Our 
extensive knowledge of this system was greatly facilitated by the early development 
of the C2 cell line (1), which differentiates to form contractile myotubes in vitro, and 
by the discovery of a key transcription factor, MyoD, on the basis of its ability to 
induce the myogenic programme when introduced into non-muscle cells (2). Three 
related proteins, Myf5 (3), Myogenin (4, 5) and Mrf4 (also known as Myf6 or herculin: 
6-8) were discovered shortly after. All four belong to the basic helix-loop-helix super 
family of proteins that bind to the E-box sequence, CANNTG, and all induce 
myogenic conversion when transfected into fibroblasts. These Myogenic Regulatory 
Factors (MRFs) form the core of the transcriptional cascade that leads to the skeletal 
muscle phenotype and therefore key questions in the field have been how these 
genes are turned on at the onset of myogenesis in the embryo and how do the 
encoded proteins function to trigger the terminal differentiation programme and 
subsequent organogenesis. 
All skeletal muscle cells have the ability to produce a contractile force that 
changes the length and shape of the cell and can thus generate motion. While this 
general property is shared by all of the skeletal muscles of our body, the origins of 
these muscles during embryogenesis vary widely (Figure 1). In this review we will 
consider our current knowledge of the regulation and function of the MRFs including 
the distinct genetic networks that control myogenesis at various locations in the 
embryo. 
Origins of skeletal muscle  
The origins of the various skeletal muscle groups were initially studied by 
grafting experiments in avian embryos although more recently genetic approaches in 
the mouse have been used. The muscles of the trunk include those that move the 
vertebral column, the muscles that form the thoracic and abdominal body walls, and 
those that cover the pelvic area. Trunk muscles derive from somites, which are 
transient paraxial mesodermal structures that form pairwise by the sequential 
segmentation of the presomitic mesoderm. The dorsal-most layer of the somite, the 
dermomyotome (DM), is the source of both myogenic and dermal progenitors of the 
trunk. During development the myotome, the first muscle in the embryo, forms below 
the DM by cell delamination from the dorso-medial lip to produce a post-mitotic, 
differentiated muscle layer termed the epaxial myotome (9, 10). Shortly after, 
myoblasts from the ventro-lateral lip (VLL) also begin migrating, contributing to the 
hypaxial myotome followed by delamination of cells from the lateral (rostral and 
caudal) lips of the DM (11-13). Like the cells of the hypaxial trunk muscles, limb 
muscle precursor cells originate from the VLL of the DM at the level of the developing 
limb (14, 15). They delaminate and migrate into the limb bud where they re-associate 
and form primary myofibres. 
The skeletal muscles of the head are responsible for the motion of the jaw, 
face, eyes and ears and are therefore critical for activities such as feeding, sensing 
and vocalisation. According to their function, muscles of the head and neck can be 
divided into four groups: branchiomeric, laryngoglossal, extraocular and axial.  
The branchial arches (BAs) contribute to the development of craniofacial 
muscles and produce the majority of the muscles of mastication and facial 
expression. The branchiomeric mesenchyme, the core of the BAs, is form by cranial 
paraxial mesoderm and neural crest (NC) cells that migrate around 9.5dpc (16, 17). It 
is from the central cell population in the core that skeletal muscle arises. Recent work 
by Grenier et al. (18) suggests that some mixing of the NC-derived and mesodermal 
populations takes place, with NC cells within the mesodermal core being essential for 
the formation of the tendons and other connective elements of the head. It has 
recently been shown that splanchnic mesodermal precursors contribute to some 
lower jaw muscles (19), while extensive clonal analysis reveals common progenitors 
contributing to both extraocular and branchiomeric muscles (20). After migration into 
the BA core, myogenic progenitor cells leave the arches and move to their final 
positions within the head mesenchyme where they differentiate into functional 
muscle blocks.  
The extraocular muscles (EOMs) surround the eyeball and are responsible 
for the fine-tuned movements of the eyes. During development, the EOMs are 
formed by migratory cells from the first branchial arch (20) and cells from the cranial 
mesoderm located in the periocular region, the prechordal mesoderm (21, 22). The 
glossal muscles combine muscles of the tongue and the muscles anchoring the 
tongue to the jaw. These muscles are derived from the four anterior-most somites, 
the occipital somites, with migratory populations delaminating from the VLL and 
migrating in a manner similar to those of the limb, although not as individual cells but 
as a coherent group of migrating cells. 
In the transition zone between the head and the trunk are the axial neck 
muscles. Due to their location it has not been clear if the origin of this group of 
muscles was cranial or trunk mesoderm but recent data confirm that they are formed 
from myoblasts of the occipital lateral plate mesoderm (23). 
Gene Regulatory Networks involved in skeletal muscle development 
The process of cell differentiation depends on the activity of a specific set of 
regulatory genes, that is, genes encoding transcription factors and signalling 
molecules. The recognition and binding of transcription factors to specific DNA target 
sequences is one of the central foundations of Gene Regulatory Networks (GRNs) 
(24). The idea of understanding and predicting the complex control systems 
underlying animal development has become a new field in biology and computational 
research. These GRNs can be defined as genomic regulatory codes, which function 
to determine the sets of genes that must be expressed in specific spatial and 
temporal patterns. Complex spatio-temporal processes of differential gene 
expression rule embryonic development and demand an extremely tight control of 
transcriptional regulation. The formation of skeletal muscle has been one of the 
developmental systems most studied in recent decades, initially because of the 
availability of muscle cell lines able to recapitulate the entire differentiation process to 
form myotubes. However in vivo this process involves a number of different steps 
that will result in a functional differentiated cell. The complexity of this scenario 
requires an intricate network of transcription factors and cis-regulatory target 
sequences essential for the differentiation and homeostasis of skeletal muscle 
progenitors. 
Despite the differences in their embryological origins, all myogenic progenitor 
cells share the same core components of the myogenic pathway which is formed by 
the MRFs: Myf5, MyoD, Mrf4 and Myogenin (Figure 2). The deployment of these 
varies according to the particular precursor population giving rise to muscle. 
Expression of the MRF proteins during development is under strict temporal and 
spatial control. Myf5 is expressed before the adoption of the myogenic fate and, 
based on the information derived from Myf5 null mice, is considered a determination 
factor. Likewise, MyoD expression in a Myf5−/− background drives cells to the 
myogenic lineage, albeit with a delay in some populations (25). Mrf4 and MyoG 
expression is later and they were traditionally classed as genes involved in the 
process of differentiation. However, we now know that Mrf4 is expressed at the same 
time as, if not before, Myf5 in the somitic bud and that in the absence of Myf5 and 
MyoD, Mrf4 is able to induce myogenesis, indicating that Mrf4 should be reclassified 
as having both differentiation and determination activity (26, 27). Most of the 
myogenic programme is severely affected only when both Myf5 and MyoD are 
absent. The Myf5−/−:MyoD−/− embryo fails to develop any skeletal muscle (28) 
although as Mrf4 expression is compromised in cis in the Myf5 allele, the necessity of 
both Myf5 and MyoD was not entirely demonstrated. Indeed, a new Myf5 allele in 
which Mrf4 expression is not affected (27) shows that in the case of the EOMs, either 
Myf5 or Mrf4 is required for their formation (29). The Myogenin knockout has an 
equally remarkable phenotype with perinatal death. While myoblasts are formed 
there is a complete absence of functional skeletal muscle supporting the idea that 
Myogenin regulates the later stages of myogenic differentiation, whilst Myf5 and 
MyoD (and in some cases Mrf4) are involved in the process of determination (30, 
31). 
There is also evidence that this distinction between MRFs is present at the 
molecular level. It was demonstrated that MYOD, MYF5 and MRF4, but not 
MYOGENIN, are able to remodel repressive chromatin environments through 
recruiting SWI/SNF proteins (ATP-dependent chromatin remodelling enzymes) in 
order to promote muscle differentiation (32-34).  
The activation of the core myogenic cascade occurs in all tissues destined for 
the skeletal myogenic lineage; however, the factors which initiate the cascade differ 
radically in the different locations of the embryo. The first evidence for this came from 
the analysis of the double Pax3;Myf5(Mrf4) knockout animals (with Mrf4 expression 
disrupted in cis). These mutant mice lack all skeletal muscle in the trunk but show no 
abnormalities in craniofacial musculature suggesting the presence of separate 
specification pathways in the trunk and the head (35). Importantly, although trunk 
myogenesis is severely impaired in Pax3 KO animals, the early specification is 
unaffected and progenitors expressing Myf5 are clearly identifiable at 10.5dpc (36), 
indicating that Pax3 could act at the level of survival or proliferation and not as a 
specifying factor of early trunk myoblasts.  
Deletion of the genes encoding the homeobox proteins MEOX1 and MEOX2 
results in a severe disruption to the patterning of the somites and skeletal muscle of 
the trunk is severely compromised, indicating a role for the MEOX proteins in 
somitogenesis and trunk myogenesis (37). Skeletal muscles of the head were 
unaffected in these mutants, despite their expression of MEOX proteins. We now 
know that there is much greater heterogeneity in the upstream activators of the 
cascade. 
Several studies have identified factors controlling the myogenic cascade 
specifically in the head: TBX1 is a T-box factor required for the formation of the BA- 
derived muscles (38). Its inactivation results in a severely atrophied BA2 and in the 
sporadic development of first arch-derived muscles (39). A mesodermal-specific 
knockout of the Tbx1 gene shows that the requirement for Tbx1 in BA myogenesis is 
cell- autonomous, and thus that the phenotype is not the result of a general 
disruption of craniofacial morphogenesis (40). PITX2 is a paired-like homeodomain 
transcription factor with a role in the specification of myogenic precursors in the BAs. 
Inactivation of Pitx2 results in increased cell death in the arch mesodermal cores and 
loss of Musculin (MSC or MyoR)-positive cells in the first BA with the resulting 
expression of Myf5, MyoD and Myog being compromised (41, 42). MSC and TCF21 
(epicardin/capsulin/POD-1) are bHLH transcription factors, known to be markers of 
undifferentiated muscle precursor cells (43). Although mice lacking either Msc or 
Tcf21 show normal facial musculature development, the compound Msc;Tcf21 
mutant fails to activate MRF expression in the first BA and the major muscles of 
mastication are missing (44). We have recently shown that Msc and Tcf21 control the 
transcription levels of Myf5 and Myod in the BAs through binding to specific 
enhancers (45). We also suggested that other regulatory factors, namely Tbx1 and/or 
Pirtx2 are responsible for the onset of MRF expression in the arches.  
Islet-1 (ISL1) is a marker of the splanchnic mesoderm and tracing studies 
using ISL1-cre label branchiomeric muscles to varying extents (46). Recent work 
introduced Lhx2 as a new player in the GRN during branchiomeric muscle 
development (47). The knockout of this gene results in pharyngeal muscle 
specification defects and epistatic relationships between Tbx1, Lhx2, and Myf5 were 
described, affecting early pharyngeal muscle specification and patterning. 
Furthermore, retrospective clonal analyses also show the presence of common 
progenitors to heart and facial muscles, indicating that these progenitors have the 
ability to contribute to two different muscle phenotypes. While the activation of Lhx2 
is probably linked to the skeletal muscle phenotype, it is still not clear if the "default" 
phenotype is cardiac muscle or if additional inputs are required for its specification, 
nor if the fate of those progenitors that have failed to become skeletal muscle can 
adopt other, non-muscle, fates or contribute exclusively to the cardiac musculature. 
An investigation into the putative fate changes of these dual progenitors in the 
different KO strains (Lhx2, Isl-1, Pitx2, etc) should shed new light on these questions. 
Finally, and as previously mentioned, the deployment of the myogenic 
cascade varies according to the embryonic origin and the final location of a particular 
muscle. The GRNs, responsible for the activation of this cascade, are under the 
control of multiple signalling inputs. It is curious that, for example, head and trunk 
myogenic programs also exhibit different outcomes in response to individual 
signalling molecules and thus, whereas trunk myogenesis is promoted by the action 
of WNT and inhibited by BMPs, antagonists to WNT promote cranial myogenesis 
(48).  
Mechanisms of transcriptional regulation in muscle development 
It is now possible to ask questions about transcription factor binding, histone 
modifications and transcriptional outputs on a genome wide scale and a number of 
recent studies have applied these new technologies to the skeletal muscle paradigm. 
Cao et al. (49) used ChIP-Seq to identify the sites to which MyoD is bound in the 
chromatin of C2C12 myoblasts and differentiated myotubes derived from them. As 
expected, they found the protein bound to the control elements of genes which are 
known to be up- or down-regulated during the process of differentiation. What was 
not expected were their findings that MyoD is also bound to a very large number of 
sites which are not obviously associated with such regulated genes and that most of 
the sites are the same in myoblasts and myotubes, although in myotubes there is 
more binding to sites associated with genes up-regulated during the differentiation 
process. Most of the sites which bind MyoD are not active in a classic transfection 
assay for enhancer function and it is thus not clear whether this widespread binding 
represents hitherto unknown functions of MyoD or is simply the consequence of the 
fact that the protein will bind to all E-boxes with some affinity. Interestingly they show 
that MyoD binding causes regional, rather than local, histone acetylation. 
This group has also addressed the question of why different bHLH proteins 
drive different lineage-specific gene expression programmes (50). Just as MyoD 
regulates muscle-specific genes the closely related transcription factor NeuroD 
drives a neuronal programme. They used lentiviral transduction to introduce NeuroD 
into P19 cells, a pluripotential mouse embryonal carcinoma cell line, and thus convert 
them into neurones and MyoD into mouse embryonic fibroblasts (MEFs) converting 
them into skeletal muscle cells. It is important to note that NeuroD cannot convert 
MEFs to neurones and that MyoD cannot convert P19 cells to muscle. The data 
again show an unexpectedly high number of binding sites, for both factors. With that 
borne in mind, it is of great interest that they reveal a fascinating specificity. Both 
factors bind to the CAGCTG E-box but each also binds to a factor-specific E-box 
motif, CAGATG for NeuroD and CAGGTG for MyoD. And this binding specificity is 
reflected in function. Binding to the private E-box sequences is associated with the 
transcriptional activation of adjacent genes, whereas binding to the shared sequence 
is associated with regional epigenetic modification. They further show that binding, of 
either factor, is constrained by chromatin accessibility, as revealed by nuclease 
sensitivity assays. Thus which sites are accessible is epigenetically determined in a 
lineage specific fashion, whereas sequence-specific binding strongly influences 
which factor binds where, and which genes are subsequently activated. A major 
question for the future is how are the lineage-specific epigenetic marks set in the first 
place. 
Soleimani et al. (51) have reported a similar analysis although there are 
important differences in the procedures employed and in the conclusions reached. 
They used retroviral transduction to introduce TAP-tagged derivatives of the 
transcription factors of interest into muscle stem cells isolated from hind limb and 
then used the tag to recover the protein and its bound DNA. They found a much 
smaller number of MyoD sites and a major difference between myoblasts (1400 
sites) and myotubes (9300 sites). The exogenous protein is expressed at a higher 
level than the endogenous one but that would be expected to lead to the occupation 
of a greater number of sites, not significantly fewer. They have also analysed the 
binding of the Snail proteins, zinc-finger transcriptional repressors that recruit the 
histone deacetylases HDAC1 and 2. This work leads to some interesting mechanistic 
conclusions. They show that Snail binds to E-boxes that have a G/C-rich central 
dinucleotide, and that such sites are associated with genes that are expressed in 
myotubes, and that it does not bind to E-boxes with A/T-rich central dinucleotides 
which are associated with genes expressed in myoblasts. Thus at the onset of 
differentiation Snail must be removed in order to allow MyoD access to the myotube 
genes. They present data, some of which is derived from heterologous systems, 
which indicate that miR-30a targets Snail1 mRNA and that miR-206 targets Snail2 
mRNA and that the genes for both of these miRNAs are activated by MRFs. 
Furthermore, it is shown that over-expression of Snail blocks differentiation whereas 
siRNA against Snail induces precocious differentiation. Thus when cells receive a 
differentiation signal MRFs activate the miRNAs which mediate the destruction of the 
Snail mRNAs and as the Snail proteins turn over MyoD gains access to the 
enhancers of the genes expressed in myotubes. The details of this model require 
further work but it potentially provides a satisfying mechanistic answer to one of the 
major issues in the field. 
Blum et al. (52) have taken a somewhat complementary approach by 
identifying enhancers in C2C12 myoblasts and myotubes on the basis of histone 
marks and then examining their occupancy by RNA polymerase II, transcription 
factors and co-activators. Satisfyingly the identified enhancers that are adjacent to 
genes are linked to those expressed in the relevant cell type but only a small minority 
of the condition-specific “enhancers” are associated with transcripts, raising the 
possibility that the marks in question are found on elements with other functions. 
They use the data of Cao et al. (49) to show that MyoD binding to enhancers 
correlates with the binding of pol-II and p300 and that in MyoD-/- cells these proteins 
are not present, and that there is a marked diminution in transcription across the 
enhancers. Re-expression of MyoD in the null myoblasts restores pol-II binding and 
H3K4 monomethylation but not H3K27 acetylation while in myotubes it restores the 
acetylation as well. Re-expression experiments of this sort are potentially powerful in 
that they can help elucidate cause and effect relationships. 
In each of these papers the authors examine the sequences around the sites 
of MyoD binding and ask, by a variety of procedures, what other transcription factors 
could bind there, in the expectation that such proteins might well co-operate with 
MyoD in the initiation of the developmental programme. They find sites for proteins 
that all in the field would expect, e.g. the Mef2 factors and RUNX but also sites for 
proteins that have not been much studied in the context of myogenesis, e.g. PPAR-
gamma and c-Myb. Rhabdomyosarcomas are paediatric tumours that express many 
but not all skeletal muscle markers and have long been considered to be of skeletal 
muscle origin, although that point has not been proven. MacQuarrie et al. (53) have 
shown that several of the factors which may well bind adjacent to MyoD, e.g Mef2C 
and RUNX are expressed at lower than expected levels in the tumour cells and that 
forcing their expression induces the cells to enter the terminal skeletal muscle 
differentiation programme, thus providing strong support for the notion that they do 
act co-operatively with MyoD. 
In all of this it should be remembered that C2 cells were derived from the 
thigh muscles of a mouse that had suffered a crush injury, and they are therefore 
generally thought to be related to satellite cells. It will be important in the long run to 
acquire data of this sort from the muscle progenitor cells of the embryo at the time 
when fate decisions are being made but we do not under-estimate the technical 
challenges posed by this desire. 
More recently improvements in bioinformatics, especially the use of 
comparative genomics, have provided high-resolution conservation maps. These 
analyses allow the identification of cis-regulatory elements within particular loci able 
to drive specific gene expression. One of the best examples is the Myf5/Mrf4 locus. 
Since 1993 several studies using plasmid/BAC/YAC deletion approaches showed the 
presence of regulatory regions throughout the locus (reviewed in 54). Deletion 
experiments are time consuming and labour intensive, and thus not generally 
practicable for the characterisation of small regulatory sequences. The use of 
bioinformatic approaches comparing non-coding evolutionarily conserved regions 
between several species provides an advantageous tool to identify or redefine the 
location of those regulatory regions. Using this approach we recently reported two 
regulatory elements within the Myf5/Mrf4 locus responsible for driving specific Myf5 
expression in the ventral compartment of the somites and in the branchial arches 
during development (45, 55). We showed that the ECR-111 somite enhancer is 
regulated by the transcription factors of the TEAD family, which have been implicated 
as effectors of the hippo signalling pathway. This enhancer is also active at later 
stages in the limbs, where it is regulated by Pax3 and proteins of the Six family (56), 
and in adult satellite cells where it is under the control of Pax7 (57). As discussed 
above the branchial arch enhancer is regulated by the bHLH factors Msc and Tcf21. 
In depth analysis of the regulatory elements of this locus showed another 
degree of complexity during transcriptional regulation. Some of these elements, like 
the early epaxial enhancer are modular in nature and do not require the action of 
further enhancers for activity (58, 59). In isolation these regulatory elements drive the 
expression pattern missing when deleted from the locus. Others, by contrast, require 
the input of additional enhancers in order to establish the full expression pattern in a 
particular subset of muscle progenitors (45; J.J.C. and P.W.J.R., unpublished data). 
This complex array of regulatory elements is able to interpret the different networks 
of signals from surrounding embryonic tissues and integrate them to give rise to the 
skeletal muscle phenotype. 
It is also becoming apparent that particular signalling pathways may play 
different functions in the trunk and the limb during myogenesis. It has recently been 
shown that Shh signalling is required for the production of the ventral limb muscles 
and to regulate directional muscle cell migration in the distal limb (60, 61). Anderson 
et al. furthermore show that sites within the previously defined limb enhancer which 
bind Gli proteins in vitro are required for the activation of Myf5 expression in the 
precursors of the ventral muscle masses, although they did not provide evidence that 
Gli proteins are bound to the enhancer in vivo (60). It has previously been shown that 
in both the mouse and the zebrafish Shh signalling is not required for the activation 
of Myf5 expression in the paraxial mesoderm but rather that it acts to maintain 
expression levels once the gene is switched on (62, 63). 
Post-transcriptional regulation by miRNAs 
MicroRNAs (miRs) are small non-coding RNAs of around 20 nucleotides  
which post-transcriptionally regulate gene expression by binding to specific 
sequences in the 3’UTR of target genes (64, 65). Several lines of evidence have 
shown important effects of miRNAs in muscle development. Mice lacking Dicer, the 
enzyme responsible for miRNA maturation, specifically in skeletal muscle cells show 
abnormal muscle fibre development and reduced muscle mass (66). Recent miRNA 
transcriptome analysis in human myoblasts combined with bioinformatic-based miR-
target prediction revealed the presence of at least 60 miRNAs differentially 
expressed during myogenic differentiation (67), either upregulated (43 out of 60) or 
downregulated (17 out of 60) during myogenesis. The collection of genes targeted by 
these miRs are involved in a wide range of cellular functions (transcriptional 
regulation, cell cycle progression, protein degradation, ubiquitination, apoptosis, cell 
motility, intracellular transport, etc.) revealing the degree of complexity linked to miR 
regulation of the myogenic processes.  
Some of the best characterised muscle specific miRNAs are miR-1, miR-206 
and miR-133 and their expression has been shown to be directly regulated by MRFs 
(68, 69). By combining microarray screening and target prediction, Goljanek-Whysall 
and co-workers (70) have identified a set of miR-1 and miR-206 targets in C2C12 
cells. Interestingly the single overexpression of some of these targets disrupts the 
myogenic programme in C2C12s by different mechanisms which include cell-cycle 
exit, morphology alterations or the activation of alternative differentiation 
programmes. Furthermore, they show that sustained expression of antimiR-206 in 
C2C12 cells grown in differentiation media also affects myogenic differentiation. 
Whether the targets identified are relevant in the myogenic process during 
embryogenesis remains to be determined, specially as some have not been detected 
to date in embryonic musculature. It is also possible that these newly discovered 
targets are involved in later myogenic processes, such as muscle regeneration, 
specially if we keep in mind that the C2C12 cells probably derive from limb muscle 
satellite cells. 
Pax3 and Pax7 play several roles during embryonic myogenesis, satellite cell 
survival, self-renewal, and proliferation. It has been shown that miR-27 is responsible 
for the downregulation of Pax3 expression during terminal differentiation of skeletal 
myogenesis. On the other hand, Pax7 is specifically controlled by miR-1, miR-206 
and miR-486 in muscle progenitors. The direct control of the expression levels of 
Pax3/7 through miRs plays a role in the delicate balance between the proliferation 
and differentiation of satellite cells, and in the regeneration of injured muscle (71, 72, 
73). It has also been shown that one isoform of the paired-related homeobox gene 
Pitx2 controls the expression of Pax3 through modulating miR27 expression during 
myogenesis (74). The maintenance of the quiescent state of muscle satellite cells is 
similarly controled by miRNAs. miR-489, highly expressed in quiescent satellite cells 
and quickly downregulated during satellite-cell activation, post-transcriptionally 
suppresses the oncogene Dek, which is involved is cell proliferation (75). Most 
satellite cells transcribe the myogenic determination gene Myf5 without activating the 
myogenic program, being held in a poised state. Myf5 levels are controlled by miR-
31 and it is sequestered in mRNP granules until satellite cells are activated. Once 
activated, dissociation of granules and reduced miR-31 levels allow immediate 
release of accumulated Myf5 protein (76).   
miRNAs are not only essential for earlier cell fate decisions in progenitors but 
they are also necessary for decisions on which muscle fibre type to form. Adult 
skeletal muscle is formed by different type of fibres commonly referred to as ‘fast’ or 
‘slow’ fibres depending on which form of myosin heavy chain (Myh) is expressed. It 
has been recently shown that the control of muscle myosin content, myofibre identity, 
and muscle performance is highly dependent on miRNAs. The transcription of 
specific Myh (Myh7 and Myh7b) in slow fibres is accompanied by the repressive 
action of miRNAs (miR-208b and miR-499) on Sox6, a gene that promotes the 
expression of fast fibre Myh genes (77).  
Concluding remarks 
Only about 1.5% of mammalian genomes is comprised of protein-coding 
genes with huge intergenic ‘deserts’ occupying the majority of the remaining material 
(78-80). However, it has become clear that much of this non-protein-coding DNA is 
transcribed into a variety of classes of RNA, both large and small (81, 82). Of 
particular interest in the context of this review was the report that in activated mouse 
cortical neurons many enhancers, defined by their epigenetic marks and protein 
binding profiles, produce short, bidirectional, un-spliced and un-polyadenylated RNAs 
called eRNAs. This transcription appears to occur specifically at enhancers which are 
actively engaged in promoting mRNA synthesis (83). However, there are few data 
indicating whether these eRNAs are functionally active or are simply a by-product of 
the functional engagement of enhancers with promoters. It is not obvious how one 
would experimentally distinguish between these possibilities. In complex 
developmental loci, of which the Mrf4/Myf5 locus is a prime example, such non-
coding transcripts could play key roles in achieving the exquisitely specific regulation 
and experiments to assess this possibility are a high priority. 
The recently released ENCODE project provides a revolutionary view of the 
genome (84). Through examining many well-established cells lines using a range of 
techniques such as RNAseq, transcription factor ChIPseq, histone ChIPseq, DNAse I 
hypersensitivity and DNA methylation, a multi-layered view of the genome has been 
assembled with signatures for enhancers, non-coding RNAs and promoters 
becoming apparent. Whilst studying a single genetic locus may appear parochial in 
the face of such enterprises, there is reason to believe that applying similar methods 
to more directed, perhaps more biologically relevant, questions could reveal much 
about how gene regulation operates in vivo and especially in that most complex of 
processes, development. For that reason, application of such techniques, especially 
ChIPseq and RNAseq, to the Mrf4/Myf5 locus will doubtless reveal much about the 
dynamics of transcription factor loading and interaction as different input signals 
converge on the master regulators of the myogenic cascade. 
 
Figure Legends 
Figure 1. Origins of skeletal muscles. Vertebrate skeletal muscles originate from 
four main mesodermal progenitor populations. The presomitic mesoderm (PSM) 
gives rise to most of the body musculature through the differential contribution of the 
somitic derivatives; ventral somitic compartments give rise to body wall, limb, tongue 
and pharyngeal muscles, the later three involve a process of cell delamination and 
cell migration, while dorsal somitic compartments are thought to give rise to deep 
back muscles; the lateral plate mesoderm (LPM) contributes to some mastication 
muscles following migration through the pharyngeal arches, and to the neck 
musculature; the posterior head mesoderm (PHM) generates progenitors that also 
migrate into the pharyngeal arches: those migrating through the second arch give 
rise to the muscles of facial expression while those contributing to the first arch will 
give rise to muscles of mastication and with some contribution to the extraocular 
muscles; finally, the anterior head mesoderm (not shown) contributes progenitors 
that migrate directly to the future eye area and give rise to extraocular muscles. 
 
Figure 2. Schematic representation of Gene Regulatory Networks in the trunk, 
head and EOMs. Gene Regulatory Networks (GRNs) controlling the processes of 
determination and differentiation of skeletal muscle share a functional core formed by 
the MRFs: Mrf4, Myf5, MyoD and Myogenin. The activators of the cascade and the 
deployment of the different members of the MRF core varies depending on the 
mesodermal origin of the cells giving rise to the different muscle groups.  
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